Formulation of an HPMC gel drug reservoir system with ethanol-water as a solvent system and limonene as a penetration enhancer for enhancing in vitro transdermal delivery of nicorandil

Skin Pharmacology and Physiology

Volumn 17, Issue 6, 2004, Pages 310-320

  Al Saidan, S M ^a   Krishnaiah, Y S R ^a   Chandrasekhar, D V ^b   Lalla, J K ^c   Rama, B ^b   Jayaram, B ^b   Bhaskar, P ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b ANDHRA UNIVERSITY   (India)

^c PRIN K M KUNDNANI COLLEGE OF PHARMACY   (India)

Author keywords

Ethanol; Hydroxypropyl methylcellulose gel; In vitro transdermal permeability; Limonene; Nicorandil; Rat abdominal skin

Indexed keywords

ALCOHOL; HYDROXYPROPYLMETHYLCELLULOSE; LIMONENE; NICORANDIL; SOLVENT; WATER;

ARTICLE; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; INFRARED SPECTROSCOPY; PRIORITY JOURNAL;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIHYPERTENSIVE AGENTS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOHEXENES; MALE; METHYLCELLULOSE; NICORANDIL; PERMEABILITY; RATS; SKIN ABSORPTION; SOLVENTS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TERPENES;

EID: 8344269541     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081117     Document Type: Article

References (51)

1. Elias PM, Cooper ER, Kore A, Brown BE: Percutaneous transport in relation to stratum corneum structure and lipid composition. J Invest Dermatol 1981;76: 297-301.
2. Bouwstra JA, Gooris GS, van der Spek JA, Bras W: Structural investigations of human stratum corneum by small-angle X-ray scattering. J Invest Dermatol 1991;97:1005-1012.
3. Elias PM: The stratum corneum revisited. J Dermatol 1996;23:756-758.
4. Michniak BB, Player MR, Chapman JM, Sowell JW: Azone analogues as penetration enhancers: Effect of different vehicles on hydrocortisone acetate skin permeation and retention. J Control Release 1994;32:147-154.
5. Sato S, Hirotani Y, Ogura N, Sasaki E, Kitagawa S: Enhancing effect of N-dodecyl-2-pyrrolidone on the percutaneous absorption of 5-fluorouracil derivatives. Chem Pharm Bull (Tokyo) 1998;46:831-836.
6. Tanojo H, Bouwstra JA, Junginger HE, Bodde HE: In vitro human skin barrier modulation by fatty acids: Skin permeation and thermal analysis studies. Pharm Res 1997;14:42-49.
7. Morimoto Y, Wada Y, Seki T, Sugibayashi K: In vitro skin permeation of morphine hydrochloride during the finite application of penetration-enhancing system containing water, ethanol and l-menthol. Biol Pharm Bull 2002;25:134-136.
8. Akimoto T, Kawahara K, Nagase Y, Aoyagi T: Polymeric transdermal drug penetration enhancer: Enhancing effect of oligodimethylsiloxane containing a glucopyranosyl end group. J Control Release 2001;77:49-57.
9. Endo M, Yamamoto T, Ijuin T: Effect of nonionic surfactants on the percutaneous absorption tenoxicam. Chem Pharm Bull 1996;44:865-867.
10. Yamane MA, Williams AC, Barry BW: Terpene penetration enhancers in propylene glycol/water co-solvent systems: Effectiveness and mechanism of action. J Pharm Pharmacol 1995;47:978-989.
11. Zhao K, Singh S, Singh J: Effect of menthone on the in vitro percutaneous absorption of tamoxifen and skin reversibility. Int J Pharm 2001;219:177-181.
12. Vaddi HK, Ho PC, Chan SY: Terpenes in propylene glycol as skin-penetration enhancers: Permeation and partition of haloperidol, Fourier transform infrared spectroscopy, and differential scanning calorimetry. J Pharm Sci 2002;91:1639-1651.
13. Gao S, Singh J: In vitro percutaneous absorption enhancement of lipophilic drug tamoxifen by terpenes. J. Control Release 1998;51:193-199.
14. Zhao K, Singh J: In vitro percutaneous absorption enhancement of propranolol hydrochloride through porcine epidermis by terpenes/ethanol. J Control Release 1999;62:359-366.
15. Zhao K, Singh J: Mechanisms of percutaneous absorption of tamoxifen by terpenes: eugenol, D-limonene and menthone. J Control Release 1998;55:253-260.
16. El-Kattan AF, Asbill CS, Kim N, Michniak BB: The effects of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities. Int J Pharm 2001;215:229-240.
17. Frampton J, Buckley MM, Fitton A: Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris. Drugs 1992;44:625-655.
18. Kerins DM, Robertson RM, Robertson D: Drugs used for the treatment of myocardial ischemia; in Hardman JG, Limbird LE (eds): Goodman and Gilman's The Pharmacological Basis of Therapeutics, ed 10. New York, Mc-Graw Hill Medical Publishing Division, 2001, p 864.
19. Frydman A: Pharmacokinetic profile of nicorandil in humans: An overview. J Cardiovasc Pharmacol 1992;20(suppl 3):S34-S44.
20. Sato K, Sugibayashi K, Morimoto Y: Species differences in percutaneous absorption of nicorandil. J Pharm Sci 1991;80:104-107.
21. Sato K, Sugibayashi K, Morimoto Y, Omiya H, Enomoto N: Prediction of the in-vitro human skin permeability of nicorandil from animal data. J Pharm Pharmacol 1989;41:379-383.
22. Tipre DN, Vavia PR: Formulation optimization and stability study of transdermal therapeutic system of nicorandil. Pharm Dev Technol 2002;7:325-332.
23. Keshary PR, Chien YW: Mechanism of transdermal controlled nitroglycerin administration. 2. Assessment of rate controlling steps. Drug Dev Ind Pharm 194;10:1663-1699.
24. Bhatia KS, Gao S, Singh J: Effect of penetration enhancers and iontophoresis on the FT-IR spectrometry and LHRH permeability through porcine skin. J Control Release 1997;47:81-89.
25. Okamoto H, Hashida M, Sezaki H: Structure-activity relationship of 1-alkyl- or 1-alkenylazacycloalkanone derivatives as percutaneous penetration enhancers. J Pharm Sci 1988;77:418-424.
26. Hayton WL, Chen T: Correction of perfusate concentration for sample removal. J Pharm Sci 1982;71:820-821.
27. Ho HO, Chen LC, Lin HM, Sheu MT: Penetration enhancement by menthol combined with a solubilization effect in a mixed solvent system. J Control Release 1998;51:301-311.
28. Yamane MA, Williams AC, Barry BW: Terpene penetration enhancers in propylene glycol/water co-solvent systems: Effectiveness and mechanism of action. J Pharm Pharmacol 1995;47:978-989.
29. Williams AC, Barry BW: Terpenes and the lipid-protein partitioning theory of skin penetration enhancement. Pharm Res 1991;8:17-24.
30. Kim DD, Kim JL, Chien YW: Mutual hairless rat skin permeation-enhancing effect of ethanol/water system and oleic acid. J Pharm Sci 1996;85:1191-1195.
31. Walker RB, Smith EW: Role of percutaneous penetration enhancers. Adv Drug Deliv Rev 1996;18:295-301.
32. Berner B, Otte JH, Mazzenga GC, Steffens RJ, Ebert CD: Ethanol:water mutually enhanced transdermal therapeutic system. 1. Nitroglycerin solution properties and membrane transport. J Pharm Sci 1989;78:314-318.
33. Kligman AM, Christophers E: Preparation of isolated sheets of human stratum corneum. Arch Dermatol 1963;88:70-73.
34. Bronaugh RL, Stewart RF, Simon M: Methods for in vitro percutaneous absorption studies. 7. Use of excised human skin. J Pharm Sci 1986;75:1094-1097.
35. Megrab NA, Williams AC, Barry BW: Estradiol permeation across human skin, silastic and snake skin membranes: Effects of ethanol/water co-solvent systems. Int J Pharm 1995;116:101-112.
36. Kim MK, Zhao H, Lee CH, Kim DD: Formulation of a reservoir-type testosterone transdermal delivery system. Int J Pharm 2001;219:51-59.
37. Raghavan SL, Trividic A, Davis AF, Hadgraft J: Effect of cellulose polymers on supersaturation and in vitro membrane transport of hydrocortisone acetate. Int J Pharm 2001;193:231-237.
38. El-Kattan AF, Asbill CS, Kim N, Michniak BB: Effect of formulation variables on the percutaneous permeation of ketoprofen from gel formulations. Drug Deliv 2000;7:147-153.
39. Rafiee-Tehrani M, Mehramizi A: In vitro release studies of piroxicam from oil-in-water creams and hydroalcoholic gel topical formulations. Drug Dev Ind Pharm 2000;26:409-414.
40. Wu P, Huang Y, Fang J, Tsai Y: Percutaneous absorption of captopril from hydrophilic cellulose derivatives through excised rabbit skin and human skin. Drug Dev Ind Pharm 1998;24:179-182.
41. El-Kattan AF, Asbill CS, Michniak BB: The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems. Int J Pharm 2000;198:179-189.
42. Wade A, Weller P: Handbook of Pharmaceutical Excipients, ed 2. Washington, American Pharmaceutical Association, 1995.
43. Diez I, Colom H, Moreno J, Obach R, Peraire C, Domenech J: A comparative in vitro study of transdermal absorption of a series of calcium channel antagonists. J Pharm Sci 1991;80:931-934.
44. Arellano A, Santoyo S, Martin C, Ygartua P: Enhancing effect of terpene on the in vitro percutaneous absorption of diclofenac sodium. Int J Pharm 1996;130:141-145.
45. Cornwell PA, Barry BW, Stoddart CP, Bouwstra JA: Wide-angle X-ray diffraction of human stratum corneum: Effects of hydration and terpene enhancer treatment. J Pharm Pharmacol 1994;46:938-950.
46. Takahashi K, Sakano H, Yoshida M, Numata N, Mizuno N: Characterization of the infl uences of polyol fatty acid esters on the permeation of diclofenac through rat skin. J Control Release 2001;73:351-358.
47. Yui N, Okuhara M, Okano M, Sakurai Y: Change in water structure in the stratum corneum of hairless rat skin by subcutaneous enhancers and its effect on indomethacin permeation. Jap J Drug Deliv Sys 1992;7:1199-1203.
48. Casal HL, Mantsch HH: Polymeric phase behaviour of phospholipid membranes studied by infrared spectroscopy. Biochim Biophys Acta 1984;779:381-401.
49. Goates CY, Knutson K: Enhanced permeation of polar compounds through human epidermis. 1. Permeability and membrane structural changes in the presence of short chain alcohols. Biochim Biophys Acta 1994;1195:169-179.
50. Golden GM, Guzek DB, Harris RR, McKie JE, Potts RO: Lipid thermotropic transitions in human stratum corneum. J Invest Dermatol 1986;86:255-259.
51. Yum S, Lee E, Taskovich L and Theeuwes F: Permeation enhancement with ethanol: Mechanism of action through skin; in Hsich DS (ed): Drug Permeation Enhancement. New York, Dekker, 1994, pp 143-170.